VERTEX PHARMAC. DL-,01 earnings per share and revenue

VX1 earnings per share for the last quarter are 4.41 EUR whereas the estimation was 3.77 EUR which accounts for 16.87% surprise. Företagets omsättning för samma period uppgår till 2.49 B EUR trots den uppskattade siffran 2.39 B EUR. Estimated earnings per share for the next quarter are 3.84 EUR, and revenue is expected to reach 2.45 B EUR. Also watch annual changes over time to get a bigger picture of VX1 earnings per share and revenue dynamics.